Enhancement of the cytotoxic activity of Clostridium difficile toxin A by surface-associated antigens

References

1. Borriello S. P., Ketley J. M., Mitchell T. J., Barclay F. E., Welch A. R., Price A. B., Stephen J. 1987; Clostridium difficile – a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis. J Med Microbiol 24:53–64 [CrossRef]
   [Google Scholar]
2. Deacon A. G., Duerden B. I., Holbrook W. P. 1978; Gas–liquid chromatographic analysis of metabolic products in the identification of Bacteroidaceae of clinical interest. J Med Microbiol 11:81–99 [CrossRef]
   [Google Scholar]
3. Drudy D., Harnedy N., Fanning S., Hannan M., Kyne L. 2007; Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile . Infect Control Hosp Epidemiol 28:932–940 [CrossRef]
   [Google Scholar]
4. Geric B., Carman R. J., Rupnik M., Genheimer C. W., Sambol S. P., Lyerly D. M., Gerding D. N., Johnson S. 2006; Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis 193:1143–1150 [CrossRef]
   [Google Scholar]
5. Kamiya S., Reed P. J., Borriello S. P. 1989; Purification and characterisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction. J Med Microbiol 30:69–77 [CrossRef]
   [Google Scholar]
6. Krivan H. C., Wilkins T. D. 1987; Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin. Infect Immun 55:1873–1877
   [Google Scholar]
7. McCoubrey J., Poxton I. R. 2001; Variation in the surface layer proteins of Clostridium difficile . FEMS Immunol Med Microbiol 31:131–135 [CrossRef]
   [Google Scholar]
8. Péchiné S., Janoir C., Collignon A. 2005; Variability of Clostridium difficile surface proteins and specific serum antibody response in patients with Clostridium difficile -associated disease. J Clin Microbiol 43:5018–5025 [CrossRef]
   [Google Scholar]
9. Péchiné S., Janoir C., Boureau H., Gleizes A., Tsapis N., Hoys S., Fattal E., Collignon A. 2007; Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile . Vaccine 25:3946–3954 [CrossRef]
   [Google Scholar]
10. Poxton I. R., Byrne M. D. 1981; Immunological analysis of Clostridium difficile and related species. J Gen Microbiol 122:41–46
    [Google Scholar]
11. Poxton I. R., Cartmill T. D. I. 1982; Immunochemistry of the cell-surface carbohydrate antigens of Clostridium difficile . J Gen Microbiol 128:1365–1370
    [Google Scholar]
12. Poxton I. R., McCoubrey J., Blair G. 2001; The pathogenicity of Clostridium difficile . Clin Microbiol Infect 7:421–427 [CrossRef]
    [Google Scholar]
13. Sharp J., Poxton I. R. 1986; Analysis of the membrane lipocarbohydrate antigen of Clostridium difficile by polyacrylamide gel electrophoresis and immunoblotting. FEMS Microbiol Lett 34:97–100 [CrossRef]
    [Google Scholar]
14. Warny M., Pepin J., Fang A., Killgore G., Thompson A., Brazier J., Frost E., McDonald L. C. 2005; Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079–1084 [CrossRef]
    [Google Scholar]